Literature DB >> 17035371

Serum phosphate and outcomes in PD patients.

David Ansell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17035371     DOI： 10.1093/ndt/gfl593

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  6 in total

1.  Peritoneal membrane phosphate transport status: a cornerstone in phosphate handling in peritoneal dialysis.

Authors:  Ana Paula Bernardo; Sebastián Azorin Contesse; Maria Auxiliadora Bajo; Anabela Rodrigues; Gloria Del Peso; Marta Ossorio; António Cabrita; Rafael Selgas
Journal:  Clin J Am Soc Nephrol       Date:  2010-11-29       Impact factor: 8.237

2.  Multidisciplinary Team versus a "Phosphate-Counting" App for Serum Phosphate Control: A Randomized Controlled Trial.

Authors:  Ana Cecilia Farfan-Ruiz; Daniel Czikk; Julie Leidecker; Tim Ramsay; Brendan McCormick; Kumanan Wilson; Deborah Zimmerman
Journal:  Kidney360       Date:  2020-12-15

3.  Peritoneal phosphate clearance is influenced by peritoneal dialysis modality, independent of peritoneal transport characteristics.

Authors:  Sunil V Badve; Deborah L Zimmerman; Greg A Knoll; Kevin D Burns; Brendan B McCormick
Journal:  Clin J Am Soc Nephrol       Date:  2008-09-24       Impact factor: 8.237

4.  Phosphate Removal by Peritoneal Dialysis: The Effect of Transporter Status and Peritoneal Dialysis Prescription.

Authors:  Cecile Courivaud; Andrew Davenport
Journal:  Perit Dial Int       Date:  2015-07-29       Impact factor: 1.756

5.  Diabetes Mellitus and Younger Age Are Risk Factors for Hyperphosphatemia in Peritoneal Dialysis Patients.

Authors:  Rameez Imtiaz; Steven Hawken; Brendan B McCormick; Simon Leung; Swapnil Hiremath; Deborah L Zimmerman
Journal:  Nutrients       Date:  2017-02-17       Impact factor: 5.717

6.  Meal phosphate variability does not support fixed dose phosphate binder schedules for patients treated with peritoneal dialysis: a prospective cohort study.

Authors:  Simon Leung; Brendan McCormick; Jessica Wagner; Mohan Biyani; Susan Lavoie; Rameez Imtiaz; Deborah Zimmerman
Journal:  BMC Nephrol       Date:  2015-12-09       Impact factor: 2.388
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.